![David Greenwood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Greenwood
Direktor/Vorstandsmitglied bei
Checkerspot, Inc.
Profil
David L.
Greenwood is currently a Director at Checkerspot, Inc. He previously served as President, Interim CEO, CFO & Director at Geron Corp.
from 1995 to 2011.
He was also Chairman at CohBar, Inc. from 2019 to 2023.
Additionally, he has served as Chairman at ViaGen, Inc. and Geron Bio-Med Ltd., Chairman at Corium International, Inc. from 2010 to 2018, and Chairman at TA Therapeutics Ltd. He has also served as a Director at Pacific Lutheran University and Clone International Pty Ltd. Furthermore, he was an Independent Director at Parnell Pharmaceuticals Holdings Ltd. from 2014 to 2015.
Mr. Greenwood received his undergraduate degree from Pacific Lutheran University and his MBA from Harvard Business School.
Aktive Positionen von David Greenwood
| Unternehmen | Position | Beginn |
|---|---|---|
Checkerspot, Inc.
 Checkerspot, Inc. BiotechnologyHealth Technology Operates as a biology-driven platform that develops healthy fats and oils | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Greenwood
| Unternehmen | Position | Ende |
|---|---|---|
| COHBAR | Vorsitzender | 10.11.2023 |
| CORIUM INTERNATIONAL INC | Vorsitzender | 27.11.2018 |
| PARL PHAR | Direktor/Vorstandsmitglied | 28.09.2015 |
| GERON CORPORATION | Finanzdirektor/CFO | - |
Pacific Lutheran University
 Pacific Lutheran University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Ausbildung von David Greenwood
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
CohBar, Inc.
 CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
ViaGen, Inc.
 ViaGen, Inc. Agricultural Commodities/MillingProcess Industries Provides genomics and assisted breeding services to the animal industry | Process Industries |
Pacific Lutheran University
Pacific Lutheran University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Geron Bio-Med Ltd. | |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
TA Therapeutics Ltd.
 TA Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Conducts research and develops therapeutics based on telomerase activator drugs to restore the functional and regenerative capacity of cells | Commercial Services |
Clone International Pty Ltd.
 Clone International Pty Ltd. Agricultural Commodities/MillingProcess Industries Specializes in the cloning of agricultural animals | Process Industries |
Parnell Pharmaceuticals Holdings Ltd.
 Parnell Pharmaceuticals Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company that develops, manufactures and markets animal pharmaceutical products | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkerspot, Inc.
Checkerspot, Inc. BiotechnologyHealth Technology Operates as a biology-driven platform that develops healthy fats and oils | Health Technology |
